The present disclosure relates generally to devices and systems for use in the medical field, and various methods associated with such devices and systems. More particularly, this disclosure relates to devices and systems used in medical procedures involving the removal of a medium from coronary circulation, and various methods associated therewith.
Coronary circulation is the circulation of blood in the vessels that supply blood to and from the heart muscle (the myocardium). The heart is supplied by the right and left coronary arteries and is drained mainly by veins that empty into the coronary sinus.
Angiography is a medical imaging technique in which an X-ray or fluoroscopic image is taken to visualize the lumen of blood vessels and organs of the body. To assist in the visualization process, a contrast media may be added to the blood.
One of the more common angiography procedures performed is the visualization of the coronary arteries. Typically in this procedure, a catheter is used to administer the contrast media into one of the two major coronary arteries. X-ray images of the contrast media within the blood allow visualization of the size, anatomy, and patency of the arterial vessels.
Contrast media, however, can have significant health risks if permitted to flow systemically to the patient's organs. For example, renal dysfunction or failure may occur from such systemic delivery of contrast media. Such dysfunction or failure is referred to as “contrast-induced nephropathy” or CIN.
Systems and methods have been developed for the removal of contrast media and other mediums from the coronary circulation. For example, in some removal methods, a removal catheter is positioned to collect medium as it exits the coronary circulation. In general, conventional systems used to collect and remove medium from the coronary circulation, and the associated conventional methods, can be improved.
The present disclosure relates to a catheter system used in removing a medium from coronary circulation. In one aspect, the catheter system functions to determine the timing of removal, and is based upon a start time and a volume of an injection. In another aspect, the catheter system employs the use of at least one external sensor.
A variety of examples of desirable product features or methods are set forth in part in the description that follows, and in part will be apparent from the description, or may be learned by practicing various aspects of the disclosure. The aspects of the disclosure may relate to individual features as well as combinations of features, including combinations of features disclosed in separate embodiments. It is to be understood that both the foregoing general description and the following detailed description are explanatory only, and are not restrictive of the claimed invention.
Reference will now be made in detail to exemplary aspects of the present disclosure that are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts.
Contrast media is used to visualize the coronary vasculature as part of coronary diagnostic and therapeutic interventional procedures. The contrast media is toxic to the kidneys and may cause kidney impairment (contrast induced nephropathy), especially in patients with pre-existing kidney disease. Accordingly, contrast removal devices and procedures including catheters for the collection and removal of contrast have been developed. The procedures include inserting the catheter into the coronary sinus (the main vein draining the heart). As the injected contrast media passes through the heart and arrives in the coronary sinus, a negative pressure is applied to the catheter and the contrast mixed with blood is removed from the body. Continuous collection or removal of fluid from the coronary sinus can cause excessive blood loss. Therefore, timing of the removal is critical.
The present system and method relate to the timing of contrast removal from a vessel, such as the coronary sinus. In determining the most effective time for removal of contrast media from the coronary sinus, several events and/or factors are considered.
One factor is the transit time through the myocardium, from coronary artery to coronary sinus. Transit time has been studied in patients with normal and diseased coronary arteries. In the study, a marker solution was injected into the coronary artery; the arrival of the marker as well as the washout of the marker through the coronary sinus was monitored. The results of this study demonstrate that the transit time is relatively consistent for patients with normal coronary arteries. In particular, the marker arrived in the coronary sinus within two seconds after the start of a coronary arterial injection, and washed through the coronary sinus within an average of seven to eight seconds. Patients with obstructed coronary arteries exhibited similar transit time profiles, only with a slightly lengthened washout time. Other published studies as well as direct observations, show the transit time for contrast injected in the coronary arteries to arrive in the coronary sinus is within 4 to seconds. The longer transit time for contrast may be due to its increased viscosity. The present method and system utilizes this information to improve upon conventional methods of removing a medium from the coronary sinus.
Referring now to
The system 10 further includes an injection sensor 18 and an interface unit 20. The interface unit 20 is electrically connected to both of the injection sensor 18 and the aspiration unit 16. During use, the interface unit 20 controls the operation of the collection catheter 14. What is meant by ‘controls the “operation” of collection catheter’ is that the interface unit 20 controls the activation and deactivation of the aspiration unit 16, which is in fluid communication with the collection catheter 14.
In some removal devices, a sensor is incorporated into a removal catheter and positioned internal to the coronary circulation system of the patient. The sensor is used to detect the arrival of contrast in a coronary vessel. Such internal sensors add significant complexity and cost into the design and manufacturing of the removal catheter. The present system provides a less complex and less costly design than that of systems having sensors placed within a patient's body during use. In particular, the injection sensor 18 of the present system 10 is remote, or located external to the patients' body during use of the system. In the illustrated embodiment, the injection sensor 18 is located between an injection syringe 22 and the injection catheter 12.
Referring still to
In particular, in the one method, the syringe 22 is used to inject the medium into the injection catheter 12. The injection of the medium is detected in the injection catheter 12 by way of the injection sensor 18 prior to the medium reaching the patient's coronary artery. The sensor 18 can include a pressure sensor, flow sensor, impedance sensor, or other sensor that detects or measures a specific parameter of an injection, or of the medium in the injection.
The sensor 18 establishes a start time of the injection. Operation of the collection catheter is then automatically initiated at a predetermined time after the start time of the injection. What is meant by “automatically” is that the operation is initiated by way of the interface unit 20, as opposed to manually initiating operation (i.e., manually activating the aspiration unit 16 and/or interface unit 20). The predetermined time after the start time of the injection typically includes a delay to account for the transit time of the medium so that operation of the collection catheter coincides with the arrival of the medium in the coronary sinus. Referring to
In general, the remote sensing catheter system 10 starts or initiates removal of a medium based on the timing from a coronary arterial injection. In addition to determining the timing for removal, the present system 10 can be used to determine whether or not the coronary arterial injection is of a significant amount to warrant activation of the system.
In particular, physicians commonly introduce a small dosage of medium (often referred to as a “puff”) into the coronary artery for evaluation purposes. The small puffs are sometimes introduced prior to a significant injection amount, and are sometimes introduced after a significant injection amount to evaluate the ongoing procedure. Collecting fluid from the coronary sinus after the injection of a puff is typically not recommended as more blood than medium is removed, which can lead to excessive blood loss depending upon the number of puffs employed during the procedure.
The present system 10 can be used to determine whether the injection is a puff of medium or a significant amount of medium that warrants removal. In particular, the injection sensor 18 can be used to determine the volume of medium in the injection. In one method, the interface unit 20 initiates operation of the collection catheter 14 only when the volume of medium in the injection is greater than a predetermined amount. Smaller volumes of medium (puffs) are ignored and operation of the collection catheter is not initiated.
In one embodiment, the determination of the volume of medium in the injection is based upon the duration of the injection. If the injection lasts longer than a predetermined duration parameter, then a significant injection amount is declared and operation of the collection catheter is initiated at the predetermined time. Referring to
The injection sensor 18 of the present system 10 can further be used to determine the timing of ceasing operation of the collection catheter 14. In such a method, the sensor 18 establishes an end time of the injection, as well as the start time. Operation of the collection catheter is then automatically ceased a predetermined time after the end time of the injection. What is meant by “automatically” is that the operation is ceased by way of the interface unit 20, as opposed to manually ceasing operation (i.e., manually deactivating the aspiration unit 16 and/or interface unit 20). Referring to
In an alternative embodiment, the timing of ceasing operation of the collection catheter 14 can be determined by use of a sensor. Referring now to
The collection sensor 28 detects or senses the presence and/or absence of medium in the collection catheter 14. The sensor 28 can include an impedance sensor. Referring to
Still referring to
The above specification provides a complete description of the present invention. Since many embodiments of the invention can be made without departing from the spirit and scope of the invention, certain aspects of the invention reside in the claims hereinafter appended.
Number | Name | Date | Kind |
---|---|---|---|
3931815 | Takatsuki | Jan 1976 | A |
4054137 | Lee et al. | Oct 1977 | A |
4581017 | Sahota | Apr 1986 | A |
4592341 | Omagari et al. | Jun 1986 | A |
4795427 | Helzel | Jan 1989 | A |
4838872 | Sherlock | Jun 1989 | A |
4969470 | Mohl et al. | Nov 1990 | A |
5069662 | Bodden | Dec 1991 | A |
5338662 | Sadri | Aug 1994 | A |
5423745 | Todd et al. | Jun 1995 | A |
5494822 | Sadri | Feb 1996 | A |
5807311 | Palestrant | Sep 1998 | A |
5807318 | St. Goar et al. | Sep 1998 | A |
5807322 | Lindsey et al. | Sep 1998 | A |
5810757 | Sweezer, Jr. et al. | Sep 1998 | A |
5813842 | Tamari | Sep 1998 | A |
5871464 | Tryggvason et al. | Feb 1999 | A |
5871465 | Vasko | Feb 1999 | A |
6021340 | Randolph et al. | Feb 2000 | A |
6080170 | Nash et al. | Jun 2000 | A |
6093392 | High et al. | Jul 2000 | A |
6110139 | Loubser | Aug 2000 | A |
6152141 | Stevens et al. | Nov 2000 | A |
6186146 | Glickman | Feb 2001 | B1 |
6251093 | Valley et al. | Jun 2001 | B1 |
6254563 | Macoviak et al. | Jul 2001 | B1 |
6295990 | Lewis et al. | Oct 2001 | B1 |
6342214 | Tryggvason et al. | Jan 2002 | B1 |
6376471 | Lawrence, III et al. | Apr 2002 | B1 |
6398752 | Sweezer et al. | Jun 2002 | B1 |
6481439 | Lewis et al. | Nov 2002 | B1 |
6500158 | Ikeguchi | Dec 2002 | B1 |
6508777 | Macoviak et al. | Jan 2003 | B1 |
6554819 | Reich | Apr 2003 | B2 |
6558349 | Kirkman | May 2003 | B1 |
6569147 | Evans et al. | May 2003 | B1 |
6585716 | Altman | Jul 2003 | B2 |
6595963 | Barbut | Jul 2003 | B1 |
6638264 | Tryggvason et al. | Oct 2003 | B1 |
6638268 | Niazi | Oct 2003 | B2 |
6673039 | Bridges et al. | Jan 2004 | B1 |
6689090 | Tryggvason et al. | Feb 2004 | B1 |
6699231 | Sterman et al. | Mar 2004 | B1 |
6726651 | Robinson et al. | Apr 2004 | B1 |
6935344 | Aboul-Hosn et al. | Aug 2005 | B1 |
6980843 | Eng et al. | Dec 2005 | B2 |
6992070 | Donahue et al. | Jan 2006 | B2 |
7211073 | Fitzgerald et al. | May 2007 | B2 |
7300429 | Fitzgerald et al. | Nov 2007 | B2 |
7331922 | Mohl | Feb 2008 | B2 |
7363072 | Movahed | Apr 2008 | B2 |
7722596 | Shapland et al. | May 2010 | B2 |
8152786 | Shapland et al. | Apr 2012 | B2 |
20010052345 | Niazi | Dec 2001 | A1 |
20020062121 | Tryggvason et al. | May 2002 | A1 |
20020077595 | Hundertmark et al. | Jun 2002 | A1 |
20020091349 | Reich | Jul 2002 | A1 |
20020099254 | Movahed | Jul 2002 | A1 |
20020107504 | Gordon | Aug 2002 | A1 |
20020165598 | Wahr et al. | Nov 2002 | A1 |
20020169436 | Gurm et al. | Nov 2002 | A1 |
20030138350 | Macoviak | Jul 2003 | A1 |
20030163081 | Constantz et al. | Aug 2003 | A1 |
20030191434 | Dorros et al. | Oct 2003 | A1 |
20030236533 | Wilson et al. | Dec 2003 | A1 |
20040002159 | Xiao et al. | Jan 2004 | A1 |
20040030286 | Altman | Feb 2004 | A1 |
20040099596 | Naghavi et al. | May 2004 | A1 |
20040102732 | Naghavi et al. | May 2004 | A1 |
20040102766 | Poleo, Jr. | May 2004 | A1 |
20040210239 | Nash et al. | Oct 2004 | A1 |
20040254523 | Fitzgerald et al. | Dec 2004 | A1 |
20050010189 | Toomey et al. | Jan 2005 | A1 |
20050124969 | Fitzgerald et al. | Jun 2005 | A1 |
20050192548 | Dolliver et al. | Sep 2005 | A1 |
20050197531 | Cabiri et al. | Sep 2005 | A1 |
20050226855 | Alt et al. | Oct 2005 | A1 |
20050256441 | Lotan et al. | Nov 2005 | A1 |
20050273014 | Gianchandani et al. | Dec 2005 | A1 |
20060013772 | LeWinter et al. | Jan 2006 | A1 |
20070078352 | Pijls | Apr 2007 | A1 |
20070118072 | Nash | May 2007 | A1 |
20070203445 | Kaye et al. | Aug 2007 | A1 |
20070255162 | Abboud et al. | Nov 2007 | A1 |
20080021314 | Movahed | Jan 2008 | A1 |
20080108960 | Shapland et al. | May 2008 | A1 |
20080125698 | Gerg et al. | May 2008 | A1 |
20080125746 | Shapland et al. | May 2008 | A1 |
20080306425 | Al-Rashdan | Dec 2008 | A1 |
20090018526 | Power | Jan 2009 | A1 |
20090069829 | Shturman | Mar 2009 | A1 |
20090187131 | Fitzgerald et al. | Jul 2009 | A1 |
20090234321 | Shapland et al. | Sep 2009 | A1 |
20100041984 | Shapland et al. | Feb 2010 | A1 |
20100082004 | Shapland et al. | Apr 2010 | A1 |
20100168564 | Shapland et al. | Jul 2010 | A1 |
20100274173 | Shapland et al. | Oct 2010 | A1 |
20110015558 | Kaye et al. | Jan 2011 | A1 |
20110172558 | Shapland et al. | Jul 2011 | A1 |
20130079697 | Kaye | Mar 2013 | A1 |
Number | Date | Country |
---|---|---|
10102045 | Jan 2003 | DE |
0 301 854 | Feb 1989 | EP |
0 150 960 | Jan 1990 | EP |
0 526 102 | Apr 1998 | EP |
1859826 | Nov 2007 | EP |
2 125 487 | Mar 1984 | GB |
2001 526071 | Dec 2001 | JP |
WO 8901309 | Feb 1989 | WO |
WO 9220387 | Nov 1992 | WO |
WO 9831405 | Jul 1998 | WO |
WO 9856440 | Dec 1998 | WO |
WO 9906097 | Feb 1999 | WO |
WO 9929227 | Jun 1999 | WO |
WO 9930765 | Jun 1999 | WO |
WO 9931982 | Jul 1999 | WO |
WO 0100268 | Jan 2001 | WO |
WO 0113983 | Mar 2001 | WO |
WO 0183004 | Nov 2001 | WO |
WO 0197901 | Dec 2001 | WO |
WO 02060511 | Aug 2002 | WO |
WO 02087677 | Nov 2002 | WO |
WO 03070330 | Aug 2003 | WO |
WO 2004083817 | Sep 2004 | WO |
WO 2005027995 | Mar 2005 | WO |
WO 2005082440 | Sep 2005 | WO |
WO 2006004882 | Jan 2006 | WO |
WO 2006004882 | Jan 2006 | WO |
WO 2006042219 | Apr 2006 | WO |
WO 2007002154 | Jan 2007 | WO |
WO 2007143288 | Dec 2007 | WO |
WO 2008122048 | Oct 2008 | WO |
Entry |
---|
Texas heart Institute Journal; Transcatheter Coronary Artery Diagnostic Techniques, vol. 16, No. 3, dated: 1989; 9 pgs. |
Alfayoumi, F. et al., The No-Reflow Phenomenon: Epidemiology, Pathophysiology and Therapeutic Approach, Review in Cardiovascular Medicine, vol. 6, No. 2, (2005); pp. 72-83. |
Assali, A. et al., “Intracoronary Adenosine Administered During Precutaneous Intervention in Acute Myocardial Infarction and Reduction in the Incidence of “No Reflow” Phenomenon”, Catheterization and Cardiovascular Interventions, vol. 51 (2000); pp. 27-31. |
De Lentos, J. et al., “New Tools for Assessing Microvascular Obstructions in Patients with ST Elevation Myocardial Infarction”, Heart, vol. 90, (2004); pp. 119-120. |
Kramer, C., “The Prognostic Significance of Microvascular Obstruction After Myocardial Infarction as Defined by Cardiovascular Magnetic Resonance”, European Heart Journal, vol. 26, (2005): pp. 532-533. |
Marzilli, M et al., “Primary Coronary Angioplasty in Acute Myocardial Infarction: Clincial Correlates of he “No Reflow” Phenomenon”, International Journal of Cardiology, vol. 65 (Suppl. 1) (1998); pp. S23-S28. |
Michishita et al., “A Novel Contrast Removal System from the Coronary Sinus Using an Absorbing Column During Coronary Angiogaphy in a Porcine Model”, Journal of the American College of Cardiology, vol. 47, No. 9, 2006; 6 pages. |
Resnic, F. et al., “No-Reflow is an independent Predictor of Death and Myocardial Infarction after Percutaneous Coronary Intervention”, American Heart Journal, vol. 145, No. 1, (2003); pp. 42-46. |
Schräder, “Contrast: Media-Induced Renal Failure: An Overview”, Journal of Interventional Cardiology, vol. 18, No. 6; (2005); pp. 417-423. |
del Monte et al., “Improvement in Survival and Cardiac Metabolism After Gene Transfer of Sarcoplasmic Reticulum CA2+-ATPase in a Rat Model of Heart Failure”, Circulation, 104(12): 1424-1429, 2001. |
Hajjar et al., “Modulation of Ventricular Function Through Gene Transfer in Vivo”, Proc. Natl. Acad. Sci., USA, 95: 5251-5256, 1998. |
Logeart, D. et al., “How to Optimize In Vivo Gene Transfer to Cardiac Myocyotes: Mechanical or Pharmacological Procedures?”, Human Gene Therapy, 12: 1601-1610, 2001. |
PCT International Search Report and Written Opinion in Application PCT/US2009/051336, mailed Feb. 19, 2010, 13 pgs. |
Fried, Steven et al., “Safe, compact and portable system for regional chemotherapeutic hyperthermic perfusion procedures”, Journal of Extra-corporeal Technology, vol. 25, No. 1, pp. 22-26 (1993). |
Number | Date | Country | |
---|---|---|---|
20100042069 A1 | Feb 2010 | US |